STXS ▲ +0.7% - Stereotaxis, Inc. $STXS - FDA 510K Clearance on name Stereotaxis shares rose 0.7% following FDA 510(k) clearance for a product bearing the company's name. The 510(k) clearance, which permits the company to market a medical device as substantially equivalent to existing predicate devices, represents regulatory approval that removes a barrier to commercialization. This type of clearance typically supports investor confidence by enabling the company to move forward with sales of the cleared device. 31-AUG-2026 11:09 AM ET